FDA 510(k) Clearance for DJO’s Exprt Revision Hip

By Julie A. Vetalice

DJO Global announced FDA 510(k) clearance for the Exprt® Revision Hip, to be priced up to 70% lower than comparable revision hip devices.

The full-line modular femoral stem was inspired by the clinical success of Wagner-style implants, and offers an anatomical design. Further, the two-tray system represents an 80% to 90% reduction in instruments vs. competitive systems.

The company's Exprt™ Precision revision knee launched in 2015.

DJO Global is offering a preview of the Exprt Revision Hip at the 2017 AAOS meeting in Booth #1733.

Sources: DJO Global; ORTHOWORLD Inc.

Product Labels: Hip Replacement

Tags: 510(k) Clearance, Regulatory